Trial Profile
Compare efficacy and safety of alpha1-blockers in patients with benign prostatic hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary) ; Naftopidil
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 09 Sep 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 03 Apr 2015 Status changed from recruiting to active, no longer recruiting, according to University Hospital Medical Information Network - Japan record.
- 03 Apr 2015 Planned End Date changed from 31 Mar 2015 to 30 Sep 2014, according to University Hospital Medical Information Network - Japan record.